BE882732A - Medicaments injectables a action anti-inflammatoire et leur preparation - Google Patents

Medicaments injectables a action anti-inflammatoire et leur preparation

Info

Publication number
BE882732A
BE882732A BE0/200183A BE200183A BE882732A BE 882732 A BE882732 A BE 882732A BE 0/200183 A BE0/200183 A BE 0/200183A BE 200183 A BE200183 A BE 200183A BE 882732 A BE882732 A BE 882732A
Authority
BE
Belgium
Prior art keywords
preparation
inflammatory action
injectable drugs
injectable
drugs
Prior art date
Application number
BE0/200183A
Other languages
English (en)
Original Assignee
Nattermann A & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nattermann A & Cie filed Critical Nattermann A & Cie
Publication of BE882732A publication Critical patent/BE882732A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/543—Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
    • A61K47/544—Phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BE0/200183A 1979-04-11 1980-04-10 Medicaments injectables a action anti-inflammatoire et leur preparation BE882732A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19792914789 DE2914789A1 (de) 1979-04-11 1979-04-11 Injizierbare arzneimittel mit entzuendungshemmender wirkung

Publications (1)

Publication Number Publication Date
BE882732A true BE882732A (fr) 1980-07-31

Family

ID=6068138

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/200183A BE882732A (fr) 1979-04-11 1980-04-10 Medicaments injectables a action anti-inflammatoire et leur preparation

Country Status (14)

Country Link
US (1) US4309420A (fr)
JP (1) JPS55147217A (fr)
AT (1) AT369650B (fr)
AU (1) AU539043B2 (fr)
BE (1) BE882732A (fr)
CA (1) CA1136048A (fr)
CH (1) CH642547A5 (fr)
DE (1) DE2914789A1 (fr)
FR (1) FR2453646A1 (fr)
GB (1) GB2047535B (fr)
IT (1) IT1148791B (fr)
NL (1) NL8002096A (fr)
SE (1) SE451428B (fr)
ZA (1) ZA802158B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3042365A1 (de) * 1980-11-10 1982-06-03 Harsanyi, Dr., Eugen, 5014 Kerpen Fluessige lecithin-haltige einphasige mehrstoffsysteme
JPS59152348A (ja) * 1983-02-19 1984-08-31 Kaken Pharmaceut Co Ltd ビフエニリルプロピオン酸エステル誘導体およびその製造法
US5196567A (en) * 1983-02-19 1993-03-23 Kaken Pharmaceutical Co., Ltd. Biphenylylpropionic acid derivative, process for preparing the same and pharmaceutical composition containing the same
US5059591B1 (en) * 1983-05-26 2000-04-25 Liposome Co Inc Drug preparations of reduced toxicity
CA1237670A (fr) * 1983-05-26 1988-06-07 Andrew S. Janoff Reduction de la toxicite de certains medicaments
JPS601122A (ja) * 1983-06-20 1985-01-07 Green Cross Corp:The ビフエニリルプロピオン酸誘導体脂肪乳剤
PT78628B (en) * 1984-05-02 1986-06-18 Liposome Co Inc Pharmaceutical composition with reduced toxicity
IL79114A (en) * 1985-08-07 1990-09-17 Allergan Pharma Method and composition for making liposomes
IT1269569B (it) * 1994-04-22 1997-04-08 Ugo Citernesi Procedimento per la preparazione di complessi fra fosfolipidi e principi attivi utili per la produzione di liposomi e principi attivi e liposomi ottenuti con il procedimento
US5763422A (en) 1995-01-27 1998-06-09 Board Of Regents, The University Of Texas System Methods of enhancing the therapeutic activity of NSAIDS and compositions of zwitterionic phospholipids useful therein
DE69621773T2 (de) * 1995-01-27 2003-01-02 Univ Texas Verfahren zur erhöhung der therapeutischen wirkung von nsaids und dazu verwendbare zwitterionische phospholipidhaltige zusammensetungen
US5955451A (en) * 1995-05-12 1999-09-21 The University Of Texas System Board Of Regents Methods of enhancing the therapeutic activity of NSAIDS and compositions of zwitterionic phospholipids useful therein
US20040077604A1 (en) 2001-12-19 2004-04-22 Lenard Lichtenberger Method and compositions employing formulations of lecithin oils and nsaids for protecting the gastrointestinal tract and providingenhanced therapeutic activity
KR102180667B1 (ko) 2011-09-29 2020-11-20 피엘엑스 옵코 인코포레이티드 위장관을 따라 약물을 표적화 방출하기 위한 pH 감응성 담체, 그로부터의 조성물, 및 이들의 제조 및 사용 방법
JP2023518822A (ja) 2020-03-26 2023-05-08 ピーエルエックス オプコ インコーポレイテッド ｐＨ依存的再構築が可能な医薬キャリア、その製造方法及び使用方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA725596A (en) * 1960-08-26 1966-01-11 J. Wretlind Arvid Method of preparing intravenously injectable fat emulsions free from side reactions or complications
GB1214515A (en) * 1967-04-11 1970-12-02 Sumitomi Chemical Company Ltd Indole derivatives and salts thereof
JPS5186117A (en) * 1975-01-27 1976-07-28 Tanabe Seiyaku Co Johoseibiryushiseizainoseiho
GB1523965A (en) * 1976-03-19 1978-09-06 Ici Ltd Pharmaceutical compositions containing steroids
US4093733A (en) * 1976-09-09 1978-06-06 Merck & Co., Inc. Parenteral suspensions
GB1575343A (en) * 1977-05-10 1980-09-17 Ici Ltd Method for preparing liposome compositions containing biologically active compounds
DE2856333C2 (de) * 1978-12-27 1983-09-22 A. Nattermann & Cie GmbH, 5000 Köln Oral einnehmbare Arzneimittel mit entzündungshemmender Wirkung

Also Published As

Publication number Publication date
AU539043B2 (en) 1984-09-06
CA1136048A (fr) 1982-11-23
NL8002096A (nl) 1980-10-14
ATA194780A (de) 1982-06-15
FR2453646B1 (fr) 1985-01-25
JPH0210805B2 (fr) 1990-03-09
DE2914789C2 (fr) 1991-05-29
ZA802158B (en) 1981-05-27
SE451428B (sv) 1987-10-12
DE2914789A1 (de) 1980-10-16
GB2047535B (en) 1983-10-26
US4309420A (en) 1982-01-05
SE8002715L (sv) 1980-10-12
CH642547A5 (de) 1984-04-30
JPS55147217A (en) 1980-11-17
AU5733080A (en) 1980-10-16
IT8021300A0 (it) 1980-04-10
GB2047535A (en) 1980-12-03
IT1148791B (it) 1986-12-03
FR2453646A1 (fr) 1980-11-07
AT369650B (de) 1983-01-25

Similar Documents

Publication Publication Date Title
BE882732A (fr) Medicaments injectables a action anti-inflammatoire et leur preparation
BE797852A (fr) Nouveau medicament a action spasmolytique et vaso-dilatatrice
BE839259A (fr) Substances antibiotiques et leur preparation
BE884077A (fr) Nouveaux tetra- et pentapeptides, leur preparation et les medicaments qui les contiennent
BR7901718A (pt) Composicoes refratarias uteis para a preparacao de pastas injetaveis e respectivas pastas injetaveis
FR2341307A1 (fr) Pyrethrinoides a titre de medicaments et compositions pharmaceutiques les renfermant
BE800899R (fr) Composes de la serie de l'androstane a activite anesthesique et leur preparation
BE863645A (fr) Pesticides et leur preparation
BE841579A (fr) Pesticides et leur preparation
BE863702A (fr) Tetrazolylcarbamoylquinoleines et leur preparation
FR2352848A1 (fr) Copolyesters lineaires et leur application a la preparation de recipients moules
BE884075A (fr) Nouveaux dipeptides, leur preparation et les medicaments qui les contiennent
BE853407A (fr) Acides isocyanato-polysulfoniques aromatiques et leur preparation
BE864124A (fr) Compositions pharmaceutiques analgesiques et anti-inflammatoires
BE884076A (fr) Nouveaux tripeptides, leur preparation et les medicaments qui les contiennent
JPS5446841A (en) Drug substituted hapten substance and production thereof
BE883663A (fr) Structures stratifiees bitumineuses et leur preparation
BE842348A (fr) Nouvelles solutions pharmaceutiques stables et leur preparation
BE850552A (fr) 2-furanones et leur preparation
BE886774A (fr) Medicaments antiarythmiques a action prolongee leur preparation et les compositions les renferment
MC1222A1 (fr) Nouvelles 2,4-diamino-5-benzylpyrimidines,leur preparation et leur application en tant que medicaments
BE850936A (fr) Hydroxyquinoleines et leur preparation
FR2351140A1 (fr) Polyesters thermoplastiques et leur preparation
BE864290A (fr) Nouveaux aryl-hexafuranosides, leur preparation et leur application en tant que medicaments
FR2313358A1 (fr) Urethanne-polythiols et leur preparation

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: A. NATTERMANN & CIE G.M.B.H.

Effective date: 19930430